The 3 linked references in paper V. Ignatyeva I., M. Avxentyeva V., V. Omelyanovsky V., G. Khachatryan R., В. Игнатьева И., М. Авксентьева В., В. Омельяновский В., Г. Хачатрян Р. (2015) “Клинико-экономическое моделирование результатов использования T-SPOT.TB у иммуноскомпрометированных детей // MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN” / spz:neicon:pharmacoeconomics:y:2014:i:3:p:12-19

  1. Ayieko J., Abuogi L., Simchowitz B., Bukusi E.A., Smith A.H., Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis. 2014 Feb 20; 14: 91. doi: 10.1186/1471-2334-14-91. PubMed PMID: 24555539; PubMed Central PMCID: PMC3936889.
  2. Centers for Disease Control and Prevention. [Title]. MMWR. 2010; 59 (No. RR-5).
  3. Centers for Disease Control and Prevention. [Title]. MMWR. 2010; 59 (No. RR-5).